{"transactions":[{"id":4617146,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-14T21:00:42.000Z","date":"2026-09-10","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":54.96,"value":274800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $54.92 to $54.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":168640,"source":{"system":"sec-edgar","filing":"0001437749-26-030343","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1407451/000143774926030343/rdgdoc.xml","form_type":"4"}},{"id":693504,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-07T21:00:53.000Z","date":"2026-08-07","kind":"gift","planned":false,"acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"2. Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":173640,"source":{"system":"sec-edgar","filing":"0001437749-26-026608","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926026608/rdgdoc.xml","form_type":"4"}},{"id":693503,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-07T21:00:53.000Z","date":"2026-08-07","kind":"gift","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"2. Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":174090,"source":{"system":"sec-edgar","filing":"0001437749-26-026608","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926026608/rdgdoc.xml","form_type":"4"}},{"id":693502,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-07T21:00:53.000Z","date":"2026-08-06","kind":"gift","planned":false,"acquired":false,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"2. Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":174590,"source":{"system":"sec-edgar","filing":"0001437749-26-026608","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926026608/rdgdoc.xml","form_type":"4"}},{"id":738532,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Stock Tracking Unit","published_at":"2026-06-15T21:03:16.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock tracking unit (\"STU\") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."}],"balance_after":8325,"derivative":{"underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0001437749-26-020679","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774926020679/rdgdoc.xml","form_type":"4"}},{"id":738462,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true}}],"security":"Stock Tracking Unit","published_at":"2026-06-15T21:02:39.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock tracking unit (\"STU\") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."}],"balance_after":8325,"derivative":{"underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0001437749-26-020677","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020677/rdgdoc.xml","form_type":"4"}},{"id":738461,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true}}],"security":"Stock Tracking Unit","published_at":"2026-06-15T21:02:04.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock tracking unit (\"STU\") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."}],"balance_after":8325,"derivative":{"underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0001437749-26-020676","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020676/rdgdoc.xml","form_type":"4"}},{"id":738460,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true}}],"security":"Stock Tracking Unit","published_at":"2026-06-15T21:01:28.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock tracking unit (\"STU\") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."}],"balance_after":8325,"derivative":{"underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0001437749-26-020675","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020675/rdgdoc.xml","form_type":"4"}},{"id":738459,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Stock Tracking Unit","published_at":"2026-06-15T21:00:53.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock tracking unit (\"STU\") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant."}],"balance_after":8325,"derivative":{"underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0001437749-26-020673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020673/rdgdoc.xml","form_type":"4"}},{"id":928152,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-29T22:24:42.000Z","date":"2026-01-29","kind":"gift","planned":false,"acquired":false,"shares":13197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a bona fide gift by the Reporting Person to the Reporting Person's children. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":179690,"source":{"system":"sec-edgar","filing":"0001437749-26-002439","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926002439/rdgdoc.xml","form_type":"4"}},{"id":928151,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-29T22:24:42.000Z","date":"2026-01-28","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a bona fide gift by the Reporting Person to the Reporting Person's children. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":192887,"source":{"system":"sec-edgar","filing":"0001437749-26-002439","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926002439/rdgdoc.xml","form_type":"4"}},{"id":942647,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-01-09T22:16:39.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":622000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":9778086,"source":{"system":"sec-edgar","filing":"0001437749-26-001016","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926001016/rdgdoc.xml","form_type":"4"}},{"id":942645,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-01-09T22:15:33.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/27, 1/1/28, 1/1/29, and 1/1/30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":798111,"source":{"system":"sec-edgar","filing":"0001437749-26-001015","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926001015/rdgdoc.xml","form_type":"4"}},{"id":989196,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-25T22:31:57.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":32.57,"value":162850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":223816,"source":{"system":"sec-edgar","filing":"0001437749-25-036358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925036358/rdgdoc.xml","form_type":"4"}},{"id":1005221,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-07T22:01:49.000Z","date":"2025-11-05","kind":"gift","planned":false,"acquired":false,"shares":803717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the transfer of shares to The Weiss Family and Descendants Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":9156086,"source":{"system":"sec-edgar","filing":"0001437749-25-033888","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925033888/rdgdoc.xml","form_type":"4"}},{"id":1005220,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-07T22:01:49.000Z","date":"2025-11-05","kind":"gift","planned":false,"acquired":false,"shares":3865126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents distribution of shares upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":9959803,"source":{"system":"sec-edgar","filing":"0001437749-25-033888","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925033888/rdgdoc.xml","form_type":"4"}},{"id":1042193,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-12T20:42:45.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":20852,"price":32.24,"value":672268.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy the Reporting Person's income tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $32.22 to $32.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":94061,"source":{"system":"sec-edgar","filing":"0001437749-25-028952","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774925028952/rdgdoc.xml","form_type":"4"}},{"id":1110361,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:47:20.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":36.94,"value":369400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":228816,"source":{"system":"sec-edgar","filing":"0001437749-25-020546","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925020546/rdgdoc.xml","form_type":"4"}},{"id":1110360,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:47:20.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":14718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":238816,"source":{"system":"sec-edgar","filing":"0001437749-25-020546","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925020546/rdgdoc.xml","form_type":"4"}},{"id":1110359,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:47:02.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":21408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":222887,"source":{"system":"sec-edgar","filing":"0001437749-25-020545","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925020545/rdgdoc.xml","form_type":"4"}},{"id":1110358,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:46:18.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":14718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":279653,"source":{"system":"sec-edgar","filing":"0001437749-25-020543","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925020543/rdgdoc.xml","form_type":"4"}},{"id":1110357,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:45:58.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":14718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":192748,"source":{"system":"sec-edgar","filing":"0001437749-25-020541","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925020541/rdgdoc.xml","form_type":"4"}},{"id":1110427,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:45:35.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":14718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":114913,"source":{"system":"sec-edgar","filing":"0001437749-25-020540","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774925020540/rdgdoc.xml","form_type":"4"}},{"id":1201789,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-18T21:01:41.000Z","date":"2025-03-17","kind":"gift","planned":false,"acquired":false,"shares":62459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to a trust for the benefit of Mr. Hume's dependents."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":178030,"source":{"system":"sec-edgar","filing":"0001437749-25-008284","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925008284/rdgdoc.xml","form_type":"4"}},{"id":1213260,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-11T21:00:42.000Z","date":"2025-03-10","kind":"gift","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":201479,"source":{"system":"sec-edgar","filing":"0001437749-25-007052","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925007052/rdgdoc.xml","form_type":"4"}},{"id":1291148,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-01-30T22:17:24.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":13824929,"source":{"system":"sec-edgar","filing":"0001437749-25-002292","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925002292/rdgdoc.xml","form_type":"4"}},{"id":1291147,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-30T22:15:48.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/26, 1/1/27, 1/1/28, and 1/1/29."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":708111,"source":{"system":"sec-edgar","filing":"0001437749-25-002290","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925002290/rdgdoc.xml","form_type":"4"}},{"id":1308904,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-07T23:01:15.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":10021,"price":28.534,"value":285939.214,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":660611,"source":{"system":"sec-edgar","filing":"0001437749-25-000662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925000662/rdgdoc.xml","form_type":"4"}},{"id":1308903,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-07T23:01:15.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":11337,"price":30.294,"value":343443.078,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":670632,"source":{"system":"sec-edgar","filing":"0001437749-25-000662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925000662/rdgdoc.xml","form_type":"4"}},{"id":1369871,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-12T22:02:38.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":30.44,"value":152200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":100195,"source":{"system":"sec-edgar","filing":"0001437749-24-034597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774924034597/rdgdoc.xml","form_type":"4"}},{"id":1369764,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-12T22:01:39.000Z","date":"2024-11-12","kind":"gift","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":207479,"source":{"system":"sec-edgar","filing":"0001437749-24-034595","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924034595/rdgdoc.xml","form_type":"4"}},{"id":1369763,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-12T22:01:39.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":30.195,"value":754875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price. The range of prices for the shares sold was $30.17 to $30.29. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":212479,"source":{"system":"sec-edgar","filing":"0001437749-24-034595","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924034595/rdgdoc.xml","form_type":"4"}},{"id":1373284,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-07T21:35:48.000Z","date":"2024-11-05","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":24.48,"value":489600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":224098,"source":{"system":"sec-edgar","filing":"0001437749-24-033950","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924033950/rdgdoc.xml","form_type":"4"}},{"id":1473890,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:07:53.000Z","date":"2024-06-20","kind":"sale","planned":false,"acquired":false,"shares":16348,"price":16.87,"value":275790.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":105195,"source":{"system":"sec-edgar","filing":"0001437749-24-020851","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774924020851/rdgdoc.xml","form_type":"4"}},{"id":1473889,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:07:53.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":22250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a grant of restricted shares that will vest on June 14, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":121543,"source":{"system":"sec-edgar","filing":"0001437749-24-020851","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774924020851/rdgdoc.xml","form_type":"4"}},{"id":1473888,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:07:53.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":9585,"price":16.39,"value":157098.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":99293,"source":{"system":"sec-edgar","filing":"0001437749-24-020851","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774924020851/rdgdoc.xml","form_type":"4"}},{"id":1473837,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:07:09.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":22250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":240489,"source":{"system":"sec-edgar","filing":"0001437749-24-020850","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924020850/rdgdoc.xml","form_type":"4"}},{"id":1473836,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:05:55.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":22250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":264935,"source":{"system":"sec-edgar","filing":"0001437749-24-020849","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924020849/rdgdoc.xml","form_type":"4"}},{"id":1473835,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:05:00.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":22250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":244098,"source":{"system":"sec-edgar","filing":"0001437749-24-020848","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924020848/rdgdoc.xml","form_type":"4"}},{"id":1473834,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:04:15.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":22250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":237479,"source":{"system":"sec-edgar","filing":"0001437749-24-020847","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924020847/rdgdoc.xml","form_type":"4"}},{"id":1575518,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-15T20:37:48.000Z","date":"2024-03-13","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":15.935,"value":79675.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":108878,"source":{"system":"sec-edgar","filing":"0001437749-24-008124","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000143774924008124/rdgdoc.xml","form_type":"4"}},{"id":1579381,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-13T20:52:24.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":22000,"price":15.97,"value":351340.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold was $15.95 to $16.00. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":215229,"source":{"system":"sec-edgar","filing":"0001437749-24-007662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924007662/rdgdoc.xml","form_type":"4"}},{"id":1644078,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-15T02:53:50.000Z","date":"2023-12-15","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust."}],"balance_after":641969,"source":{"system":"sec-edgar","filing":"0001437749-24-004259","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924004259/rdgdoc.xml","form_type":"5"}},{"id":1684681,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-08T23:33:18.000Z","date":"2024-01-05","kind":"sale","planned":false,"acquired":false,"shares":17500,"price":19.03,"value":333025.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 58,732 shares on January 4, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. Mr. Charney had no discretion with respect to such sale, which was transacted in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold was $19.01 to $19.06. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":237229,"source":{"system":"sec-edgar","filing":"0001437749-24-000900","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000900/rdgdoc.xml","form_type":"4"}},{"id":1684680,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-08T23:32:45.000Z","date":"2024-01-06","kind":"grant","planned":false,"acquired":true,"shares":1001908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":13074929,"source":{"system":"sec-edgar","filing":"0001437749-24-000899","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000899/rdgdoc.xml","form_type":"4"}},{"id":1686257,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-05T22:00:59.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":681969,"source":{"system":"sec-edgar","filing":"0001437749-24-000756","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000756/rdgdoc.xml","form_type":"4"}},{"id":1686256,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-05T22:00:59.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":47867,"price":16.91,"value":809430.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":606969,"source":{"system":"sec-edgar","filing":"0001437749-24-000756","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000756/rdgdoc.xml","form_type":"4"}},{"id":1771772,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T21:02:13.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":113878,"source":{"system":"sec-edgar","filing":"0001104659-23-105403","document":"tm2327273-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000110465923105403/tm2327273-5_4seq1.xml","form_type":"4"}},{"id":1771752,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T21:01:49.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":218239,"source":{"system":"sec-edgar","filing":"0001104659-23-105400","document":"tm2327273-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923105400/tm2327273-4_4seq1.xml","form_type":"4"}},{"id":1771751,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T21:01:00.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":242685,"source":{"system":"sec-edgar","filing":"0001104659-23-105394","document":"tm2327273-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923105394/tm2327273-3_4seq1.xml","form_type":"4"}},{"id":1771750,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T21:00:42.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":221848,"source":{"system":"sec-edgar","filing":"0001104659-23-105389","document":"tm2327273-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923105389/tm2327273-2_4seq1.xml","form_type":"4"}},{"id":1771749,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T21:00:18.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":254729,"source":{"system":"sec-edgar","filing":"0001104659-23-105383","document":"tm2327273-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923105383/tm2327273-1_4seq1.xml","form_type":"4"}},{"id":1809042,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2023-08-14T13:54:15.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":10.13,"value":1013000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.11 to $10.17. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":12073021,"source":{"system":"sec-edgar","filing":"0001104659-23-091054","document":"tm2323684-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923091054/tm2323684-1_4seq1.xml","form_type":"4"}},{"id":1844600,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-06-26T21:00:28.000Z","date":"2023-06-23","kind":"sale","planned":false,"acquired":false,"shares":34854,"price":23.37,"value":814537.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 75,399 shares on June 22, 2023, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's tax withholding obligations. Mr. Lonial had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":93878,"source":{"system":"sec-edgar","filing":"0001104659-23-074784","document":"tm2319687-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000110465923074784/tm2319687-1_4seq1.xml","form_type":"4"}},{"id":1868065,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2023-06-05T22:26:42.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":73647,"price":26.7,"value":1966374.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 148,750 shares on May 31, 2023, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":654836,"source":{"system":"sec-edgar","filing":"0001104659-23-068182","document":"tm2317823-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923068182/tm2317823-1_4seq1.xml","form_type":"4"}},{"id":1955173,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2023-03-14T21:00:47.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2024, 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, and 1/4 will vest on 1/1/2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":728483,"source":{"system":"sec-edgar","filing":"0001104659-23-032338","document":"tm239588-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923032338/tm239588-2_4seq1.xml","form_type":"4"}},{"id":1955172,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2023-03-14T21:00:32.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":985000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":11973021,"source":{"system":"sec-edgar","filing":"0001104659-23-032337","document":"tm239588-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923032337/tm239588-1_4seq1.xml","form_type":"4"}},{"id":2060955,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-06T22:01:10.000Z","date":"2023-01-06","kind":"purchase","acquired":true,"shares":9000,"price":10.64,"value":95760.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":201848,"source":{"system":"sec-edgar","filing":"0001104659-23-001901","document":"tm232483-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923001901/tm232483-2_4seq1.xml","form_type":"4"}},{"id":2060954,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-06T22:00:48.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":30000,"price":11.1,"value":333000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 100,878 shares on January 1, 2023, 30,000 shares were sold in order to cover the reporting person's income tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold was $10.91 to $11.38. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":234729,"source":{"system":"sec-edgar","filing":"0001104659-23-001900","document":"tm232483-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923001900/tm232483-1_4seq1.xml","form_type":"4"}},{"id":2203529,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-22T20:34:23.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a grant of options relating to 2021 service and performance, of which 1/3 will vest on 7/20/2024, 1/3 will vest on 7/20/2025, and 1/3 will vest on 7/20/2026."}],"balance_after":1900000,"derivative":{"exercise_price":7,"expiration_date":"2027-07-20","underlying":"Common Stock, par value $0.001","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001104659-22-082027","document":"tm2221660-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082027/tm2221660-7_4seq1.xml","form_type":"4"}},{"id":2203528,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-22T20:33:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects a grant of options relating to 2021 service and performance, of which 1/2 will vest on 1/1/2024 and 1/2 will vest upon U.S. Food and Drug Administration approval of ublituximab as a treatment for patients with relapsing forms of multiple sclerosis."}],"balance_after":200000,"derivative":{"exercise_price":7,"expiration_date":"2027-07-20","underlying":"Common Stock, par value $0.001","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-22-082024","document":"tm2221660-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082024/tm2221660-6_4seq1.xml","form_type":"4"}},{"id":2203527,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-22T20:33:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/3 will vest on 1/1/2023, 1/3 will vest upon U.S. Food and Drug Administration approval of ublituximab as a treatment for patients with relapsing forms of multiple sclerosis, and 1/3 will vest upon approval by the European Medicines Agency of ublituximab."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":643483,"source":{"system":"sec-edgar","filing":"0001104659-22-082024","document":"tm2221660-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082024/tm2221660-6_4seq1.xml","form_type":"4"}},{"id":2203550,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T20:32:59.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":43732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":128732,"source":{"system":"sec-edgar","filing":"0001104659-22-082023","document":"tm2221660-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000110465922082023/tm2221660-5_4seq1.xml","form_type":"4"}},{"id":2203525,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T20:32:22.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":43732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":198239,"source":{"system":"sec-edgar","filing":"0001104659-22-082022","document":"tm2221660-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082022/tm2221660-4_4seq1.xml","form_type":"4"}},{"id":2203526,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T20:31:41.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":43732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":222685,"source":{"system":"sec-edgar","filing":"0001104659-22-082020","document":"tm2221660-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082020/tm2221660-3_4seq1.xml","form_type":"4"}},{"id":2203524,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T20:31:26.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":43732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":192848,"source":{"system":"sec-edgar","filing":"0001104659-22-082018","document":"tm2221660-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082018/tm2221660-2_4seq1.xml","form_type":"4"}},{"id":2203523,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T20:31:08.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":43732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":264729,"source":{"system":"sec-edgar","filing":"0001104659-22-082016","document":"tm2221660-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082016/tm2221660-1_4seq1.xml","form_type":"4"}},{"id":2440612,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:11:53.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":9653,"price":18.31,"value":176746.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing."}],"balance_after":568483,"source":{"system":"sec-edgar","filing":"0001104659-22-002361","document":"tm222217d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002361/tm222217d1_4.xml","form_type":"4"}},{"id":2440611,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:11:53.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":75312,"price":19.2,"value":1445990.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."}],"balance_after":578136,"source":{"system":"sec-edgar","filing":"0001104659-22-002361","document":"tm222217d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002361/tm222217d1_4.xml","form_type":"4"}},{"id":2440607,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":30671,"price":18.31,"value":561586.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 2,437,005 shares received as a liquidating distribution from Opus Point Partners, LLC (\"Opus\"), of which Mr. Weiss was a principal. In prior reports, Mr, Weiss reported beneficial ownership of all 4,874,010 shares held by Opus, even though he only owned 50% of Opus. On December 29, 2021, as part of the dissolution of Opus the shares of TGTX held by Opus were distributed to the underlying Opus owners. As a result of such distribution, the 2,437,005 shares held indirectly by the reporting person are no longer held by the reporting person."}],"balance_after":10988021,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440606,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":37549,"price":19.2,"value":720940.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."}],"balance_after":13455697,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440605,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":56394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a grant of restricted shares of common stock of TG Therapeutics in lieu of cash compensation owed to Mr. Weiss for the 2021 fiscal year, which will fully vest on January 1, 2024."}],"balance_after":13493246,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440604,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-16","kind":"gift","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13436852,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440603,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-16","kind":"gift","acquired":false,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the transfer of shares of TG Therapeutics stock to various trusts for the benefit of Mr. Weiss' dependents."}],"balance_after":13445852,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440602,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-15","kind":"gift","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":14145852,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2659486,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:27:10.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares relating that will vest in according to the following schedule: 50% on January 1, 2022, and 25% on each of January 1, 2023 and 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting and 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing."}],"balance_after":653448,"source":{"system":"sec-edgar","filing":"0001104659-21-084262","document":"tm2120405-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084262/tm2120405-7_4seq1.xml","form_type":"4"}},{"id":2659485,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:26:47.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":1080770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the final annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provided the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $500 million greater than the Market Capitalization on the date of grant as measured within a five-year timeframe, but in no event before December 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,909,355 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a principal and beneficially owns a 50% interest."}],"balance_after":14148852,"source":{"system":"sec-edgar","filing":"0001104659-21-084261","document":"tm2120405-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084261/tm2120405-6_4seq1.xml","form_type":"4"}},{"id":2659579,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:26:30.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares which will vest on June 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001104659-21-084260","document":"tm2120405-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000110465921084260/tm2120405-5_4seq1.xml","form_type":"4"}},{"id":2659484,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38351,"kind":"person","name":"HUME DANIEL","position":1,"cik":"0001645514","reported_name":"HUME DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:26:09.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":154507,"source":{"system":"sec-edgar","filing":"0001104659-21-084259","document":"tm2120405-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084259/tm2120405-4_4seq1.xml","form_type":"4"}},{"id":2659483,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:25:50.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":178953,"source":{"system":"sec-edgar","filing":"0001104659-21-084258","document":"tm2120405-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084258/tm2120405-3_4seq1.xml","form_type":"4"}},{"id":2659482,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:25:29.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":149116,"source":{"system":"sec-edgar","filing":"0001104659-21-084257","document":"tm2120405-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084257/tm2120405-2_4seq1.xml","form_type":"4"}},{"id":2659481,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:25:17.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a grant of restricted shares that will vest on June 18, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":220997,"source":{"system":"sec-edgar","filing":"0001104659-21-084256","document":"tm2120405d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084256/tm2120405d1_4seq1.xml","form_type":"4"}},{"id":2659480,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":25563,"kind":"person","name":"Charney Laurence N","position":1,"cik":"0001407451","reported_name":"Charney Laurence N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:25:17.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":180997,"source":{"system":"sec-edgar","filing":"0001104659-21-084256","document":"tm2120405d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084256/tm2120405d1_4seq1.xml","form_type":"4"}},{"id":2864386,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-02-12T22:01:20.000Z","date":"2020-12-21","kind":"gift","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing."}],"balance_after":629438,"source":{"system":"sec-edgar","filing":"0001104659-21-022085","document":"tm216578d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921022085/tm216578d1_5.xml","form_type":"5"}},{"id":2864385,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-02-12T22:01:20.000Z","date":"2020-10-09","kind":"gift","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust."}],"balance_after":636438,"source":{"system":"sec-edgar","filing":"0001104659-21-022085","document":"tm216578d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921022085/tm216578d1_5.xml","form_type":"5"}},{"id":2926281,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-01-04T21:30:29.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares relating to 2020 service and performance. This award will vest in approximately equal tranches on January 1, 2022, 2023, 2024 and 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":653338,"source":{"system":"sec-edgar","filing":"0001104659-21-000339","document":"tm211514d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921000339/tm211514d1_4.xml","form_type":"4"}},{"id":2928026,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in Mr. Weiss' beneficial ownership are 4,909,355 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."}],"balance_after":13068082,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928025,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13068737,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928024,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-22","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13069737,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928023,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-15","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13069937,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928022,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-15","kind":"gift","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13070137,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928021,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-15","kind":"gift","acquired":false,"shares":834877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Weiss Family and Descendants Trust."}],"balance_after":13071837,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928020,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-09-25","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13906714,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928019,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-09-10","kind":"gift","acquired":false,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Weiss Family and Descendants Trust."}],"balance_after":13909214,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2949092,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38349,"kind":"person","name":"Echelard Yann","position":1,"cik":"0001561958","reported_name":"Echelard Yann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-12-11T22:01:14.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":30000,"price":40.05,"value":1201500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price. The range of prices for such transaction was $39.90 to $40.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":129116,"source":{"system":"sec-edgar","filing":"0001104659-20-134811","document":"tm2038329d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920134811/tm2038329d1_4.xml","form_type":"4"}},{"id":3033599,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":19524,"kind":"organization","name":"RA CAPITAL MANAGEMENT, L.P.","position":1,"cik":"0001346824","reported_name":"RA CAPITAL MANAGEMENT, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":19526,"kind":"person","name":"Kolchinsky Peter","position":2,"cik":"0001384859","reported_name":"Kolchinsky Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":19527,"kind":"person","name":"Shah Rajeev M.","position":3,"cik":"0001619841","reported_name":"Shah Rajeev M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-11T20:31:30.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":158589,"price":25.8072,"value":4092738.0408,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $25.66 to $26.08; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities include 11,298,916 shares held by RA Capital Healthcare Fund, L.P. (the \"Fund\") and 1,330,952 shares held by a separately managed account (the \"Account\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"RA Capital Management, L.P. (the \"Adviser\") is the investment manager for the Fund and the Account. The general partner of the Adviser is RA Capital Management GP, LLC (the \"Adviser GP\"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah may be deemed indirect beneficial owners of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the \"Act\"). They disclaim beneficial ownership of any of the reported securities for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii). To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, and disclaim any pecuniary interest in securities held in the Account for purposes of Rule 16a-1(a)(2)."}],"balance_after":12629868,"source":{"system":"sec-edgar","filing":"0001104659-20-104436","document":"tm2030601-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/tm2030601-1_4.xml","form_type":"4"}},{"id":3079778,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2020-07-20T23:00:17.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a special long-term incentive award consisting of a grant of restricted shares that will vest in approximately equal tranches on January 1, 2021, 2022, 2023 and 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":633338,"source":{"system":"sec-edgar","filing":"0001104659-20-084949","document":"tm2025277d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/tm2025277d1_4.xml","form_type":"4"}},{"id":3079777,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2020-07-20T23:00:17.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares relating to 2019 service and performance. This award will vest in approximately equal tranches on January 1, 2021, 2022, 2023 and 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":433338,"source":{"system":"sec-edgar","filing":"0001104659-20-084949","document":"tm2025277d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/tm2025277d1_4.xml","form_type":"4"}},{"id":3093304,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38373,"kind":"person","name":"Lonial Sagar","position":1,"cik":"0001816609","reported_name":"Lonial Sagar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-07-02T20:32:47.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, 15,000 of which will vest on June 22, 2023, and 50,000 of which will vest in approximately equal tranches on June 22, 2023, 2024 and 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001104659-20-080595","document":"tm2024075d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816609/000110465920080595/tm2024075d2_4.xml","form_type":"4"}},{"id":3101201,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-06-24T23:51:10.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":1556029,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provides the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on the date of grant, but in no event before December 31, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":14434214,"source":{"system":"sec-edgar","filing":"0001104659-20-076547","document":"tm2022959-7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/tm2022959-7_4.xml","form_type":"4"}}],"next_cursor":"2020-06-24T23:51:10.000000Z,3101201"}